{"id":7680,"date":"2026-05-18T15:52:00","date_gmt":"2026-05-18T13:52:00","guid":{"rendered":"https:\/\/hermix.com\/?p=7680"},"modified":"2026-05-18T15:52:00","modified_gmt":"2026-05-18T13:52:00","slug":"licitatie-publica-pentru-medicamente-antituberculoase-sistemice-preparate-aseptic-in-cadrul-fundatiei-nhs-din-mid-south-essex","status":"publish","type":"post","link":"https:\/\/hermix.com\/ro\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\/","title":{"rendered":"Licita\u021bie public\u0103 Mid South Essex NHS Foundation Trust pentru medicamente sistemice anticancerigene preparate aseptic"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Vede\u021bi datele complete ale licita\u021biei: <a href=\"https:\/\/app.hermix.com\/opportunities\/ukfts_033144-2026\">https:\/\/app.hermix.com\/opportunities\/ukfts_033144-2026<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Un acord-cadru \u00een valoare de pu\u021bin peste 1 miliard de lire sterline, pe o perioad\u0103 de 96 de luni, care acoper\u0103 medicamente pentru cancer cu doze fixe, specifice pacientului \u0219i CIVAS, al\u0103turi de servicii de gestionare a stocurilor, structurat pentru a deservi centrele NHS din sud-estul Angliei, East Midlands \u0219i West Midlands.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Funda\u021bia NHS Mid South Essex a publicat un anun\u021b de participare pe site-ul Serviciului de licita\u021bie din Regatul Unit (UK Find a Tender Service) pentru un acord-cadru care acoper\u0103 furnizarea de medicamente sistemice anticancerigene preparate aseptic. Valoarea total\u0103 estimat\u0103 este de 1.003.992.346,03 EUR pe o durat\u0103 a contractului de 96 de luni, structurat pe patru loturi. Scurta descriere confirm\u0103 c\u0103 cadrul acoper\u0103 medicamente fabricate pe loturi \u00een prezent\u0103ri gata de administrare, fabricarea \u0219i furnizarea specifice pacientului, CIVAS (Serviciul Central de Aditivi Intraveno\u0219i) \u0219i gestionarea stocurilor. Dou\u0103 anun\u021buri de informare prealabil\u0103 au fost publicate \u00een mai \u0219i august 2025 \u00eenainte de apari\u021bia anun\u021bului oficial de participare \u00een aprilie 2026, semnal\u00e2nd o perioad\u0103 extins\u0103 de implicare pe pia\u021b\u0103.<\/p>\n\n\n\n\n\n\n<h2 class=\"wp-block-heading\">Prezentare general\u0103 a oportunit\u0103\u021bii<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Autoritatea contractant\u0103:<\/strong> Funda\u021bia NHS din Mid South Essex<\/li>\n\n\n\n<li><strong>Tipul cump\u0103r\u0103torului: <\/strong>Minister sau orice alt\u0103 autoritate na\u021bional\u0103 sau federal\u0103<\/li>\n\n\n\n<li><strong>Activitate principal\u0103:<\/strong> Necunoscut (conform notific\u0103rii)<\/li>\n\n\n\n<li><strong>Num\u0103r de referin\u021b\u0103:<\/strong> PR-2264<\/li>\n\n\n\n<li><strong>ID document: <\/strong>ukfts_033144-2026<\/li>\n\n\n\n<li><strong>Titlul ofertei: <\/strong>Medicamente pentru terapie sistemic\u0103 anticancerigen\u0103 preparate aseptic<\/li>\n\n\n\n<li><strong>Contact:<\/strong> Serviciu Clien\u021bi, customercare@htepg.com, 01268 524900<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Domeniul de aplicare al lucr\u0103rii, a\u0219a cum este men\u021bionat \u00een anun\u021b:<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Furnizarea unei game de medicamente sistemice anticancerigene, preparate aseptic \u0219i fabricate \u00een loturi, \u00een prezent\u0103ri gata de administrare \u0219i \u00een intervale de dozare convenite.<\/li>\n\n\n\n<li>Fabricarea \u0219i furnizarea de medicamente sistemice anticancerigene specifice pacientului<\/li>\n\n\n\n<li>Cerin\u021be CIVAS (Serviciul Central de Administrare Aditiv\u0103 Intravenoas\u0103)<\/li>\n\n\n\n<li>Gestionarea stocurilor \u0219i furnizarea de terapie sistemic\u0103 anticancerigen\u0103 preparat\u0103<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Structura lotului (valoare-cadru comun\u0103 pentru toate loturile):<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Lotul 1:<\/strong> Medicamente pentru terapie sistemic\u0103 anticancerigen\u0103 cu doze echilibrate (1.003.992.346,03 EUR): Medicamente SACT preparate aseptic cu doze echilibrate pentru pacien\u021bi adul\u021bi \u0219i copii, furnizate \u00een loturi sau unit\u0103\u021bi individuale, \u00een conformitate cu tabelele na\u021bionale cu doze echilibrate.<\/li>\n\n\n\n<li><strong>Lotul 2: <\/strong>Medicamente pentru terapie sistemic\u0103 anticancerigen\u0103 specifice pacientului (1.003.992.346,03 EUR): Medicamente pentru terapie anticancerigen\u0103 preparate aseptic, specifice pacientului, pentru pacien\u021bi adul\u021bi \u0219i copii<\/li>\n\n\n\n<li><strong>Lotul 3:<\/strong> CIVAS \/ Serviciul Central de Aditivi Intraveno\u0219i (1.003.992.346,03 EUR): Medicamente utilizate \u00een CIVA, inclusiv orice preparat de medicament manipulat aseptic pentru a crea medicamente injectabile gata de utilizare<\/li>\n\n\n\n<li><strong>Lotul 4:<\/strong> Gestionarea stocurilor \u0219i aprovizionarea cu medicamente SACT preparate (1.003.992.346,03 EUR): Depozitare, antrepozitare, gestionarea stocurilor \u0219i stocarea loturilor de medicamente SACT pentru livrare a doua zi sau \u00een ziua respectiv\u0103<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Not\u0103: Valorile loturilor afi\u0219ate sunt identice \u0219i reprezint\u0103 totalul comun al cadrului de 1.003.992.346,03 EUR, nu patru valori contractuale separate. Valoarea total\u0103 estimat\u0103 pentru cadrul de lucru este de 1.003.992.346,03 EUR.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Locul execut\u0103rii (toate loturile): <\/strong>Sud-Est (Anglia), East Midlands (Anglia), West Midlands (Anglia)<\/li>\n\n\n\n<li><strong>Tipul contractului:<\/strong> Furnituri<\/li>\n\n\n\n<li><strong>Durata contractului: <\/strong>96 de luni<\/li>\n\n\n\n<li><strong>Procedur\u0103: <\/strong>Deschide<\/li>\n\n\n\n<li><strong>Criterii de atribuire (toate loturile): <\/strong>Tehnic Inclusiv Valoare Social\u0103 (calitate) 65%, Cost (cost) 35%<\/li>\n\n\n\n<li><strong>Valoare total\u0103 estimat\u0103:<\/strong> \u20ac1,003,992,346.03<\/li>\n\n\n\n<li><strong>Data public\u0103rii: <\/strong>13 aprilie 2026<\/li>\n\n\n\n<li><strong>Termen limit\u0103 de depunere: <\/strong>11 mai 2026<\/li>\n\n\n\n<li><strong>Data deschiderii ofertelor: <\/strong>11 mai 2026<\/li>\n\n\n\n<li><strong>Finan\u021bare UE: <\/strong>Nu<\/li>\n\n\n\n<li><strong>Surs\u0103: <\/strong>G\u0103si\u021bi un serviciu de licita\u021bii \u00een Regatul Unit<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Notific\u0103ri conexe:<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>ukfts_024556-2025: Notificare de informare prealabil\u0103, publicat\u0103 la 22 mai 2025, Medicamente preparate aseptic, cu doze echilibrate<\/li>\n\n\n\n<li>ukfts_048018-2025: Notificare de informare prealabil\u0103, publicat\u0103 la 12 august 2025, Medicamente preparate aseptic, cu doze echilibrate, valoare 789.239.286,08 \u20ac<\/li>\n\n\n\n<li>ukfts_033144-2026: Anun\u021b de participare, publicat la 13 aprilie 2026, valoare 1.003.992.346,03 \u20ac<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Sunte\u021bi gata s\u0103 califica\u021bi mai rapid licita\u021bii de acest gen?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Creeaz\u0103-\u021bi contul gratuit Hermix la <a href=\"https:\/\/hermix.com\/ro\/sign-up\/\">https:\/\/hermix.com\/sign-up\/<\/a> \u0219i accesa\u021bi analize ale licita\u021biilor bazate pe inteligen\u021b\u0103 artificial\u0103, informa\u021bii competitive \u0219i monitorizare automat\u0103 pe pia\u021ba european\u0103 de achizi\u021bii publice, \u00een valoare de 2 trilioane de euro.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Autoritate \u0219i context de achizi\u021bii<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Funda\u021bia NHS Mid South Essex este clasificat\u0103 \u00een notificare drept minister sau alt\u0103 autoritate na\u021bional\u0103 sau federal\u0103, cu activitatea principal\u0103 enumerat\u0103 ca Necunoscut\u0103. Datele de contact indic\u0103 adresa customercare@htepg.com, ceea ce indic\u0103 faptul c\u0103 achizi\u021bia este gestionat\u0103 prin intermediul unui serviciu extern de achizi\u021bii, mai degrab\u0103 dec\u00e2t direct de c\u0103tre Trust. Num\u0103rul de contact 01268 524900 este \u00een concordan\u021b\u0103 cu zona Essex.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Amprenta de achizi\u021bii Hermix pentru acest cump\u0103r\u0103tor arat\u0103 urm\u0103toarele:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>78 de contracte atribuite \u00een toate categoriile, \u00een valoare total\u0103 de 1,8 miliarde de euro<\/li>\n\n\n\n<li>5 re\u00eennoiri \u00een toate categoriile, \u00een valoare total\u0103 de 838 de milioane de euro, dintre care 4 sunt clasificate drept re\u00eennoiri similare \u00een valoare de 690 de milioane de euro<\/li>\n\n\n\n<li>0 contracte similare atribuite \u00een setul de date Hermix pentru acest cump\u0103r\u0103tor specific, ceea ce \u00eenseamn\u0103 c\u0103 nu sunt urm\u0103rite atribuiri anterioare \u00een aceast\u0103 categorie \u00een baza acestei autorit\u0103\u021bi.<\/li>\n\n\n\n<li>1 licita\u021bie deschis\u0103 \u00een prezent pentru toate categoriile, \u00een valoare de 148 de milioane EUR (aceast\u0103 licita\u021bie este singura deschis\u0103; datele contextuale arat\u0103 0 licita\u021bii deschise similare, ceea ce sugereaz\u0103 c\u0103 cifra de 148 de milioane EUR se refer\u0103 la o alt\u0103 categorie)<\/li>\n\n\n\n<li>15 notific\u0103ri prealabile similare \u00een valoare total\u0103 de 3,2 miliarde de euro, al\u0103turi de 38 de notific\u0103ri prealabile \u00een valoare total\u0103 de 4,0 miliarde de euro, cele dou\u0103 PIN-uri din 2025 fac parte din acest record<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Contextul mai larg al pie\u021bei arat\u0103 al\u021bi 765 de cump\u0103r\u0103tori cu proiecte similare, reprezent\u00e2nd o valoare combinat\u0103 de 262 de miliarde de euro. Aceasta reflect\u0103 amploarea semnificativ\u0103 a produc\u021biei \u0219i achizi\u021biilor de SACT aseptice \u00een cadrul NHS \u0219i al sistemelor de s\u0103n\u0103tate europene, chiar dac\u0103 acest cump\u0103r\u0103tor specific nu are contracte similare atribuite \u00een eviden\u021b\u0103, conform Hermix.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Cele dou\u0103 anun\u021buri de informare prealabil\u0103 publicate \u00een mai \u0219i august 2025 sunt semnificative din punct de vedere strategic. Primul PIN a ap\u0103rut \u00een mai 2025 f\u0103r\u0103 o valoare. Al doilea PIN din august 2025 avea o valoare de 789.239.286,08 EUR. Anun\u021bul de participare publicat \u00een aprilie 2026 arat\u0103 un total estimat mai mare, de 1.003.992.346,03 EUR. Aceast\u0103 cre\u0219tere de aproximativ 214 milioane EUR \u00eentre al doilea PIN \u0219i anun\u021bul de participare reflect\u0103 probabil ajust\u0103ri ale domeniului de aplicare sau includerea de elemente de servicii suplimentare \u00een perioada de implicare pe pia\u021b\u0103.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Peisaj competitiv<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Setul de date Hermix nu prezint\u0103 nicio atribuire de contracte similare pentru acest cump\u0103r\u0103tor. Nu exist\u0103 un tabel cu C\u00e2\u0219tig\u0103torii Contractelor Similare disponibil \u00een PDF-ul publicat. Acest lucru este \u00een concordan\u021b\u0103 cu datele contextuale, care \u00eenregistreaz\u0103 0 atribuiri de contracte similare la 0 EUR pentru aceast\u0103 autoritate contractant\u0103. Absen\u021ba unui tabel istoric al atribuirilor \u00eenseamn\u0103 c\u0103 ofertan\u021bii nu se pot baza pe date precedente la nivel de cump\u0103r\u0103tor pentru a-\u0219i compara pozi\u021bia competitiv\u0103 sau pre\u021burile cu furnizorii anteriori.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ceea ce confirm\u0103 datele este amploarea pie\u021bei mai largi de furnizare a medicamentelor aseptice \u0219i a SACT. Hermix urm\u0103re\u0219te al\u021bi 765 de cump\u0103r\u0103tori cu proiecte similare \u00een valoare de 262 de miliarde de euro, iar acest cump\u0103r\u0103tor are \u00eenregistrate 15 notific\u0103ri prealabile similare, \u00een valoare total\u0103 de 3,2 miliarde de euro. Cele 4 re\u00eennoiri similare, \u00een valoare de 690 de milioane de euro, din setul de date, semnaleaz\u0103, de asemenea, c\u0103 contracte comparabile \u00een acest domeniu ajung \u00een mod regulat \u00een etapa de re\u00eennoire \u00een cadrul NHS. Aceast\u0103 linie de contracte regenerabile este un indicator direct al oportunit\u0103\u021bilor comerciale pe termen lung pentru furnizorii aseptici califica\u021bi, dincolo de aceast\u0103 licita\u021bie specific\u0103.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u00cen absen\u021ba unui istoric specific al contractantului la nivel de cump\u0103r\u0103tor, furnizorii care evalueaz\u0103 aceast\u0103 oportunitate ar trebui s\u0103 analizeze pia\u021ba mai larg\u0103 de aprovizionare cu medicamente SACT aseptice din cadrul NHS pentru a identifica posibilii concuren\u021bi. Pia\u021ba medicamentelor oncologice preparate aseptic din Regatul Unit este un segment specializat, dominat de un num\u0103r mic de unit\u0103\u021bi de produc\u021bie aseptic\u0103 autorizate, fie unit\u0103\u021bi interne NHS, fie produc\u0103tori comerciali speciali autoriza\u021bi de MHRA. Structura lotului aici (interval de doz\u0103, specific pacientului, CIVAS, gestionarea stocurilor) corespunde direct liniilor de servicii standard oferite de serviciile aseptice NHS consacrate \u0219i de produc\u0103torii comerciali contractuali din acest domeniu.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Semnale comerciale \u0219i procedurale<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Criterii de premiere.<\/strong> Toate cele patru loturi utilizeaz\u0103 o ponderare identic\u0103: Tehnic\u0103 Inclusiv Valoare Social\u0103 65%, Cost 35%. Ponderarea calit\u0103\u021bii 65% este ridicat\u0103 pentru un contract de furnizare de produse farmaceutice, ceea ce indic\u0103 faptul c\u0103 cump\u0103r\u0103torul pune un accent semnificativ pe capacitatea tehnic\u0103, conformitatea cu reglement\u0103rile \u0219i acredit\u0103rile de valoare social\u0103, al\u0103turi de pre\u021b. Ofertan\u021bii ar trebui s\u0103 investeasc\u0103 substan\u021bial \u00een r\u0103spunsul la calitate, \u00een special \u00een ceea ce prive\u0219te conformitatea cu GMP, capacitatea de produc\u021bie aseptic\u0103, sistemele de management al calit\u0103\u021bii \u0219i livrarea de valoare social\u0103.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Procedur\u0103. <\/strong>Achizi\u021biile publicitare utilizeaz\u0103 procedura standard deschis\u0103. Orice furnizor calificat poate depune o ofert\u0103 f\u0103r\u0103 o etap\u0103 de precalificare. Av\u00e2nd \u00een vedere complexitatea reglement\u0103rilor din domeniul produc\u021biei aseptice \u0219i al farmaciei oncologice, bariera efectiv\u0103 de calificare este stabilit\u0103 de cerin\u021bele tehnice din cadrul documenta\u021biei complete de licita\u021bie, mai degrab\u0103 dec\u00e2t de calea procedural\u0103 \u00een sine.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Acoperire geografic\u0103.<\/strong> Toate cele patru loturi specific\u0103 acela\u0219i loc de executare: Anglia de Sud-Est, East Midlands, Anglia \u0219i West Midlands, Anglia. Aceasta este o constr\u00e2ngere geografic\u0103 semnificativ\u0103, care acoper\u0103 loca\u021biile NHS dintr-o por\u021biune substan\u021bial\u0103 din centrul \u0219i sudul Angliei. Furnizorii f\u0103r\u0103 infrastructur\u0103 existent\u0103 de distribu\u021bie \u0219i lan\u021b frigorific \u00een aceste trei regiuni vor trebui s\u0103 abordeze \u00een mod explicit capacitatea logistic\u0103 \u00een depunerea lor.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Durata contractului. <\/strong>Durata de 96 de luni (8 ani) este lung\u0103 pentru un cadru de aprovizionare farmaceutic\u0103. Aceasta semnaleaz\u0103 o preferin\u021b\u0103 pentru securitatea aprovizion\u0103rii \u0219i continuitatea rela\u021biilor fa\u021b\u0103 de ciclurile competitive pe termen scurt. Un contract pe 8 ani \u00een spa\u021biul SACT impune produc\u0103torilor s\u0103 demonstreze o capacitate de produc\u021bie stabil\u0103, o situa\u021bie de reglementare \u0219i stabilitate a pre\u021burilor pe \u00eentreaga perioad\u0103.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Fereastra de trimitere.<\/strong> De la publicarea din 13 aprilie 2026 p\u00e2n\u0103 la termenul limit\u0103 din 11 mai 2026, ofertan\u021bii au la dispozi\u021bie 28 de zile calendaristice. Deschiderea licita\u021biilor este, de asemenea, pe 11 mai 2026. Pentru un cadru de aprovizionare farmaceutic\u0103 aseptic\u0103 complex din punct de vedere tehnic de aceast\u0103 dimensiune, 28 de zile este un termen foarte scurt. Furnizorii f\u0103r\u0103 o preg\u0103tire prealabil\u0103 din perioada de angajament PIN 2025 se vor confrunta cu o provocare semnificativ\u0103 \u00een a formula un r\u0103spuns conform \u0219i competitiv \u00een aceast\u0103 fereastr\u0103.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Valori partajate ale lotului. <\/strong>Cele patru loturi au aceea\u0219i valoare estimat\u0103 de 1.003.992.346,03 EUR. Acesta este totalul cadrului comun, nu o valoare separat\u0103 pentru fiecare lot. Ofertan\u021bii nu ar trebui s\u0103 interpreteze acest lucru ca \u0219i cum cadrul ar valora de patru ori mai mult dec\u00e2t cifra principal\u0103.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Context strategic \u0219i interpretare<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Cronologia achizi\u021biilor spune o poveste deliberat\u0103. Primul anun\u021b de informare prealabil\u0103 a ap\u0103rut \u00een mai 2025, cu aproape un an \u00eenainte de termenul limit\u0103 al anun\u021bului de participare. Un al doilea anun\u021b de inten\u021bie (PIN) a urmat \u00een august 2025, de data aceasta cu o valoare ata\u0219at\u0103. Anun\u021bul de participare a sosit \u00een aprilie 2026. Aceast\u0103 fereastr\u0103 de angajare extins\u0103, care se \u00eentinde pe aproape 12 luni de la primul PIN p\u00e2n\u0103 la termenul limit\u0103 de depunere, este caracteristic\u0103 achizi\u021biilor-cadru NHS cu valoare mare \u0219i complexitate tehnic\u0103, \u00een care cump\u0103r\u0103torul dore\u0219te s\u0103 se asigure c\u0103 pia\u021ba este preg\u0103tit\u0103 \u00een mod adecvat \u00eenainte de a primi oferte.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Cre\u0219terea valorii de la 789 de milioane de euro (PIN august 2025) la 1.004 milioane de euro (anun\u021b de participare din aprilie 2026) merit\u0103 men\u021bionat\u0103. Cre\u0219terea de 214 milioane de euro poate reflecta extinderea domeniului de aplicare la cele patru loturi, estim\u0103ri revizuite ale volumului sau formalizarea duratei contractuale complete de 96 de luni \u00een totalul estimat. Furnizorii care au participat la procesul PIN 2025 vor fi urm\u0103rit aceste schimb\u0103ri \u0219i \u00ee\u0219i vor fi rafinat pozi\u021biile comerciale \u0219i tehnice \u00een lunile intermediare.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Locul de executare cu trei regiuni (South East, East Midlands, West Midlands) pozi\u021bioneaz\u0103 acest lucru ca un cadru subna\u021bional, dar multi-trust. Mid South Essex NHS Foundation Trust pare s\u0103 ac\u021bioneze ca autoritate contractant\u0103 principal\u0103, poten\u021bial \u00een numele loca\u021biilor NHS din \u00eentreaga zon\u0103 geografic\u0103 acoperit\u0103. Domeniul de contact htepg.com sugereaz\u0103 c\u0103 achizi\u021bia este administrat\u0103 prin intermediul unui organism specializat de achizi\u021bii sau licita\u021bii farmaceutice NHS, ceea ce este \u00een concordan\u021b\u0103 cu complexitatea contract\u0103rii medicamentelor SACT.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Utilizatorii Hermix care analizeaz\u0103 aceast\u0103 licita\u021bie pot accesa instantaneu aceste informa\u021bii competitive, inclusiv profiluri detaliate ale contractorilor, modele de cheltuieli ale autorit\u0103\u021bilor \u0219i fluxul complet de re\u00eennoiri, \u00een c\u00e2teva minute, \u00een loc de ore.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Concluzii practice pentru ofertan\u021bi<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">Cui i se potrive\u0219te aceast\u0103 ofert\u0103:<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Unit\u0103\u021bi de produc\u021bie aseptic\u0103 autorizate MHRA, fie c\u0103 sunt produc\u0103tori interni NHS sau produc\u0103tori contractuali comerciali, cu acreditare GMP actual\u0103 \u0219i capacitate pentru produc\u021bia de SACT pe intervale de doz\u0103 \u0219i specifice pacientului<\/li>\n\n\n\n<li>Companii specializate \u00een farmacii oncologice \u0219i servicii aseptice cu rela\u021bii de furnizare stabilite cu NHS \u0219i autoriza\u021bie de reglementare pentru a furniza produse speciale f\u0103r\u0103 licen\u021b\u0103 sau produse preparate aseptic autorizate<\/li>\n\n\n\n<li>Furnizori cu logistic\u0103 \u0219i capacitate de distribu\u021bie \u00een lan\u021b frigorific care acoper\u0103 sud-estul Angliei, East Midlands \u0219i West Midlands, capabili s\u0103 livreze a doua zi sau \u00een ziua dorit\u0103 c\u0103tre mai multe loca\u021bii NHS<\/li>\n\n\n\n<li>Organiza\u021bii capabile s\u0103 demonstreze o ofert\u0103 credibil\u0103 cu valoare social\u0103 al\u0103turi de capacitatea tehnic\u0103, av\u00e2nd \u00een vedere ponderarea calit\u0103\u021bii 65% care include \u00een mod explicit valoarea social\u0103 \u00een criteriile de notare.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Puncte critice de aten\u021bie:<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Termenul limit\u0103 de depunere a ofertelor este 11 mai 2026, ceea ce \u00eenseamn\u0103 doar 28 de zile calendaristice de la publicare. Deschiderea ofertelor este, de asemenea, 11 mai 2026. Mobiliza\u021bi imediat echipa de licita\u021bie, furnizorii f\u0103r\u0103 preg\u0103tire prealabil\u0103 din cadrul angajamentelor PIN din 2025 fiind dezavantaja\u021bi semnificativ.<\/li>\n\n\n\n<li>Ponderarea criteriilor de atribuire este Tehnic\u0103, inclusiv Valoare Social\u0103 65%, Cost 35% pentru toate cele patru loturi. Investi\u021bi majoritatea resurselor ofertei \u00een r\u0103spunsul calitativ, nu \u00een modelarea pre\u021bului.<\/li>\n\n\n\n<li>Valorile celor patru loturi afi\u0219ate (fiecare 1.003.992.346,03 EUR) reprezint\u0103 totalul cadrului comun, nu valori separate. Cadrul valoreaz\u0103 aproximativ 1 miliard EUR \u00een total, nu 4 miliarde EUR.<\/li>\n\n\n\n<li>Locul de executare acoper\u0103 trei regiuni engleze. Demonstra\u021bi \u00een mod explicit \u00een depunere distribu\u021bia \u0219i acoperirea lan\u021bului frigorific \u00een sud-estul Angliei, East Midlands \u0219i West Midlands.<\/li>\n\n\n\n<li>Durata de 96 de luni necesit\u0103 dovezi credibile ale capacit\u0103\u021bii de produc\u021bie pe termen lung, mecanisme stabile de stabilire a pre\u021burilor \u0219i conformitate cu reglement\u0103rile pe un orizont de 8 ani.<\/li>\n\n\n\n<li>Revizui\u021bi ambele anun\u021buri de informare prealabil\u0103 din 2025 (ukfts_024556-2025 \u0219i ukfts_048018-2025) pentru orice cerin\u021be de implicare pe pia\u021b\u0103 sau etape de precalificare care ar fi putut preceda licita\u021bia formal\u0103.<\/li>\n<\/ul>\n\n\n\n\n\n\n<h2 class=\"wp-block-heading\">\u00cenchidere<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Aceast\u0103 achizi\u021bie se situeaz\u0103 la intersec\u021bia dintre farmacia oncologic\u0103, lan\u021bul de aprovizionare NHS \u0219i produc\u021bia aseptic\u0103, un segment specializat \u00een care statutul de reglementare, capacitatea de produc\u021bie \u0219i securitatea aprovizion\u0103rii conteaz\u0103 la fel de mult ca pre\u021bul. Durata de 96 de luni \u0219i ponderarea calit\u0103\u021bii 65% reflect\u0103 un cump\u0103r\u0103tor care prioritizeaz\u0103 fiabilitatea \u00een detrimentul minimiz\u0103rii costurilor. Pentru furnizorii califica\u021bi de SACT aseptici, termenul prelungit pentru PIN \u00eenseamn\u0103 c\u0103 fereastra de preg\u0103tire este deschis\u0103 de aproape un an. Fereastra de depunere de 28 de zile de la anun\u021bul de contract \u00eenseamn\u0103 c\u0103 aceast\u0103 fereastr\u0103 se \u00eenchide acum rapid.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Creeaz\u0103-\u021bi contul gratuit ast\u0103zi la <a href=\"https:\/\/hermix.com\/ro\/sign-up\/\">https:\/\/hermix.com\/sign-up\/<\/a> \u0219i c\u00e2\u0219tiga\u021bi mai multe contracte publice cu ajutorul abord\u0103rii bazate pe date, care ajut\u0103 companiile s\u0103 aib\u0103 succes constant \u00een v\u00e2nz\u0103rile B2G \u00een \u00eentreaga Europ\u0103.<\/p>\n\n\n<figure class=\"wp-block-post-featured-image\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1200\" height=\"628\" src=\"https:\/\/hermix.com\/wp-content\/uploads\/2026\/05\/Mid-South-Essex-NHS-Foundation-Trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines_featured-image-1.png\" class=\"attachment-post-thumbnail size-post-thumbnail wp-post-image\" alt=\"Licita\u021bie public\u0103 Mid South Essex NHS Foundation-Trust pentru medicamente sistemice anticancerigene preparate aseptic\" style=\"object-fit:cover;\" srcset=\"https:\/\/hermix.com\/wp-content\/uploads\/2026\/05\/Mid-South-Essex-NHS-Foundation-Trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines_featured-image-1.png 1200w, https:\/\/hermix.com\/wp-content\/uploads\/2026\/05\/Mid-South-Essex-NHS-Foundation-Trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines_featured-image-1-300x157.png 300w, https:\/\/hermix.com\/wp-content\/uploads\/2026\/05\/Mid-South-Essex-NHS-Foundation-Trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines_featured-image-1-1024x536.png 1024w, https:\/\/hermix.com\/wp-content\/uploads\/2026\/05\/Mid-South-Essex-NHS-Foundation-Trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines_featured-image-1-768x402.png 768w\" sizes=\"(max-width: 1200px) 100vw, 1200px\" \/><\/figure>","protected":false},"excerpt":{"rendered":"<p>View full tender data: https:\/\/app.hermix.com\/opportunities\/ukfts_033144-2026 A framework agreement worth just over \u00a31 billion across 96 months covering dose banded, patient specific and CIVAS cancer medicines alongside stock inventory management services, structured to serve NHS sites across South East, East Midlands and West Midlands England. Mid South Essex NHS Foundation Trust has published a contract notice [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":7870,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"content-type":"","inline_featured_image":false,"page_builder":"","footnotes":"","_ppma_block_editor_authors":""},"categories":[35],"tags":[],"ppma_author":[17],"class_list":["post-7680","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-tender-analysis"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.1.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"View full tender data: https:\/\/app.hermix.com\/opportunities\/ukfts_033144-2026 A framework agreement worth just over \u00a31 billion across 96 months covering dose banded, patient specific and CIVAS cancer medicines alongside stock inventory management services, structured to serve NHS sites across South East, East Midlands and West Midlands England. Mid South Essex NHS Foundation Trust has published a contract notice\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Andreea Ilie\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/hermix.com\/ro\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.1.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"ro_RO\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Hermix - Win Public Contracts with the Power of AI\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Mid South Essex NHS Foundation Trust public tender for aseptically prepared systemic anti-cancer therapy medicines - Hermix\" \/>\n\t\t<meta property=\"og:description\" content=\"View full tender data: https:\/\/app.hermix.com\/opportunities\/ukfts_033144-2026 A framework agreement worth just over \u00a31 billion across 96 months covering dose banded, patient specific and CIVAS cancer medicines alongside stock inventory management services, structured to serve NHS sites across South East, East Midlands and West Midlands England. Mid South Essex NHS Foundation Trust has published a contract notice\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/hermix.com\/ro\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/hermix.com\/wp-content\/uploads\/2026\/05\/Mid-South-Essex-NHS-Foundation-Trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines_featured-image-1.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/hermix.com\/wp-content\/uploads\/2026\/05\/Mid-South-Essex-NHS-Foundation-Trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines_featured-image-1.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-05-18T13:52:00+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-05-18T13:52:00+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/hermixapp\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:site\" content=\"@Hermix_sw\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Mid South Essex NHS Foundation Trust public tender for aseptically prepared systemic anti-cancer therapy medicines - Hermix\" \/>\n\t\t<meta name=\"twitter:description\" content=\"View full tender data: https:\/\/app.hermix.com\/opportunities\/ukfts_033144-2026 A framework agreement worth just over \u00a31 billion across 96 months covering dose banded, patient specific and CIVAS cancer medicines alongside stock inventory management services, structured to serve NHS sites across South East, East Midlands and West Midlands England. Mid South Essex NHS Foundation Trust has published a contract notice\" \/>\n\t\t<meta name=\"twitter:creator\" content=\"@Hermix_sw\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/hermix.com\/wp-content\/uploads\/2026\/05\/Mid-South-Essex-NHS-Foundation-Trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines_featured-image-1.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/hermix.com\\\/ro\\\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\\\/#blogposting\",\"name\":\"Mid South Essex NHS Foundation Trust public tender for aseptically prepared systemic anti-cancer therapy medicines - Hermix\",\"headline\":\"Mid South Essex NHS Foundation Trust public tender for aseptically prepared systemic anti-cancer therapy medicines\",\"author\":{\"@id\":\"https:\\\/\\\/hermix.com\\\/ro\\\/author\\\/andreea-ilie\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/hermix.com\\\/ro\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/hermix.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Mid-South-Essex-NHS-Foundation-Trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines_featured-image-1.png\",\"width\":1200,\"height\":628,\"caption\":\"Mid South Essex NHS Foundation-Trust public tender-for aseptically prepared systemic anti-cancer therapy medicines\"},\"datePublished\":\"2026-05-18T15:52:00+03:00\",\"dateModified\":\"2026-05-18T15:52:00+03:00\",\"inLanguage\":\"ro-RO\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/hermix.com\\\/ro\\\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/hermix.com\\\/ro\\\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\\\/#webpage\"},\"articleSection\":\"Tender Analysis, Andreea Ilie\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/hermix.com\\\/ro\\\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/hermix.com\\\/ro#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/hermix.com\\\/ro\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/hermix.com\\\/ro\\\/category\\\/tender-analysis\\\/#listItem\",\"name\":\"Tender Analysis\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/hermix.com\\\/ro\\\/category\\\/tender-analysis\\\/#listItem\",\"position\":2,\"name\":\"Tender Analysis\",\"item\":\"https:\\\/\\\/hermix.com\\\/ro\\\/category\\\/tender-analysis\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/hermix.com\\\/ro\\\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\\\/#listItem\",\"name\":\"Mid South Essex NHS Foundation Trust public tender for aseptically prepared systemic anti-cancer therapy medicines\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/hermix.com\\\/ro#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/hermix.com\\\/ro\\\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\\\/#listItem\",\"position\":3,\"name\":\"Mid South Essex NHS Foundation Trust public tender for aseptically prepared systemic anti-cancer therapy medicines\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/hermix.com\\\/ro\\\/category\\\/tender-analysis\\\/#listItem\",\"name\":\"Tender Analysis\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/hermix.com\\\/ro\\\/#organization\",\"name\":\"Hermix\",\"description\":\"Win Public Contracts with the Power of AI\",\"url\":\"https:\\\/\\\/hermix.com\\\/ro\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.hermix.com\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/hermix_logo.png\",\"@id\":\"https:\\\/\\\/hermix.com\\\/ro\\\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\\\/#organizationLogo\"},\"image\":{\"@id\":\"https:\\\/\\\/hermix.com\\\/ro\\\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/hermixapp\",\"https:\\\/\\\/twitter.com\\\/Hermix_sw\",\"https:\\\/\\\/www.instagram.com\\\/hermix_sw\\\/\",\"https:\\\/\\\/be.linkedin.com\\\/company\\\/hermix\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/hermix.com\\\/ro\\\/author\\\/andreea-ilie\\\/#author\",\"url\":\"https:\\\/\\\/hermix.com\\\/ro\\\/author\\\/andreea-ilie\\\/\",\"name\":\"Andreea Ilie\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/hermix.com\\\/ro\\\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\\\/#webpage\",\"url\":\"https:\\\/\\\/hermix.com\\\/ro\\\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\\\/\",\"name\":\"Mid South Essex NHS Foundation Trust public tender for aseptically prepared systemic anti-cancer therapy medicines - Hermix\",\"description\":\"View full tender data: https:\\\/\\\/app.hermix.com\\\/opportunities\\\/ukfts_033144-2026 A framework agreement worth just over \\u00a31 billion across 96 months covering dose banded, patient specific and CIVAS cancer medicines alongside stock inventory management services, structured to serve NHS sites across South East, East Midlands and West Midlands England. Mid South Essex NHS Foundation Trust has published a contract notice\",\"inLanguage\":\"ro-RO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hermix.com\\\/ro\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/hermix.com\\\/ro\\\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/hermix.com\\\/ro\\\/author\\\/andreea-ilie\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/hermix.com\\\/ro\\\/author\\\/andreea-ilie\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/hermix.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Mid-South-Essex-NHS-Foundation-Trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines_featured-image-1.png\",\"@id\":\"https:\\\/\\\/hermix.com\\\/ro\\\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\\\/#mainImage\",\"width\":1200,\"height\":628,\"caption\":\"Mid South Essex NHS Foundation-Trust public tender-for aseptically prepared systemic anti-cancer therapy medicines\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/hermix.com\\\/ro\\\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\\\/#mainImage\"},\"datePublished\":\"2026-05-18T15:52:00+03:00\",\"dateModified\":\"2026-05-18T15:52:00+03:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/hermix.com\\\/ro\\\/#website\",\"url\":\"https:\\\/\\\/hermix.com\\\/ro\\\/\",\"name\":\"Hermix\",\"description\":\"Win Public Contracts with the Power of AI\",\"inLanguage\":\"ro-RO\",\"publisher\":{\"@id\":\"https:\\\/\\\/hermix.com\\\/ro\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Licita\u021bie public\u0103 Mid South Essex NHS Foundation Trust pentru medicamente sistemice anticancerigene preparate aseptic - Hermix","description":"Vede\u021bi datele complete ale licita\u021biei: https:\/\/app.hermix.com\/opportunities\/ukfts_033144-2026 Un acord-cadru \u00een valoare de pu\u021bin peste 1 miliard de lire sterline, pe o perioad\u0103 de 96 de luni, care acoper\u0103 medicamente anti-cancer cu doze fixe, specifice pacientului \u0219i CIVAS, al\u0103turi de servicii de gestionare a stocurilor, structurat pentru a deservi centrele NHS din sud-estul Angliei, East Midlands \u0219i West Midlands. Mid South Essex NHS Foundation Trust a publicat un anun\u021b de participare.","canonical_url":"https:\/\/hermix.com\/ro\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/hermix.com\/ro\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\/#blogposting","name":"Mid South Essex NHS Foundation Trust public tender for aseptically prepared systemic anti-cancer therapy medicines - Hermix","headline":"Mid South Essex NHS Foundation Trust public tender for aseptically prepared systemic anti-cancer therapy medicines","author":{"@id":"https:\/\/hermix.com\/ro\/author\/andreea-ilie\/#author"},"publisher":{"@id":"https:\/\/hermix.com\/ro\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/hermix.com\/wp-content\/uploads\/2026\/05\/Mid-South-Essex-NHS-Foundation-Trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines_featured-image-1.png","width":1200,"height":628,"caption":"Mid South Essex NHS Foundation-Trust public tender-for aseptically prepared systemic anti-cancer therapy medicines"},"datePublished":"2026-05-18T15:52:00+03:00","dateModified":"2026-05-18T15:52:00+03:00","inLanguage":"ro-RO","mainEntityOfPage":{"@id":"https:\/\/hermix.com\/ro\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\/#webpage"},"isPartOf":{"@id":"https:\/\/hermix.com\/ro\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\/#webpage"},"articleSection":"Tender Analysis, Andreea Ilie"},{"@type":"BreadcrumbList","@id":"https:\/\/hermix.com\/ro\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/hermix.com\/ro#listItem","position":1,"name":"Home","item":"https:\/\/hermix.com\/ro","nextItem":{"@type":"ListItem","@id":"https:\/\/hermix.com\/ro\/category\/tender-analysis\/#listItem","name":"Tender Analysis"}},{"@type":"ListItem","@id":"https:\/\/hermix.com\/ro\/category\/tender-analysis\/#listItem","position":2,"name":"Tender Analysis","item":"https:\/\/hermix.com\/ro\/category\/tender-analysis\/","nextItem":{"@type":"ListItem","@id":"https:\/\/hermix.com\/ro\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\/#listItem","name":"Mid South Essex NHS Foundation Trust public tender for aseptically prepared systemic anti-cancer therapy medicines"},"previousItem":{"@type":"ListItem","@id":"https:\/\/hermix.com\/ro#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/hermix.com\/ro\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\/#listItem","position":3,"name":"Mid South Essex NHS Foundation Trust public tender for aseptically prepared systemic anti-cancer therapy medicines","previousItem":{"@type":"ListItem","@id":"https:\/\/hermix.com\/ro\/category\/tender-analysis\/#listItem","name":"Tender Analysis"}}]},{"@type":"Organization","@id":"https:\/\/hermix.com\/ro\/#organization","name":"Hermix","description":"Win Public Contracts with the Power of AI","url":"https:\/\/hermix.com\/ro\/","logo":{"@type":"ImageObject","url":"https:\/\/www.hermix.com\/wp-content\/uploads\/2022\/04\/hermix_logo.png","@id":"https:\/\/hermix.com\/ro\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\/#organizationLogo"},"image":{"@id":"https:\/\/hermix.com\/ro\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/hermixapp","https:\/\/twitter.com\/Hermix_sw","https:\/\/www.instagram.com\/hermix_sw\/","https:\/\/be.linkedin.com\/company\/hermix"]},{"@type":"Person","@id":"https:\/\/hermix.com\/ro\/author\/andreea-ilie\/#author","url":"https:\/\/hermix.com\/ro\/author\/andreea-ilie\/","name":"Andreea Ilie"},{"@type":"WebPage","@id":"https:\/\/hermix.com\/ro\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\/#webpage","url":"https:\/\/hermix.com\/ro\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\/","name":"Mid South Essex NHS Foundation Trust public tender for aseptically prepared systemic anti-cancer therapy medicines - Hermix","description":"View full tender data: https:\/\/app.hermix.com\/opportunities\/ukfts_033144-2026 A framework agreement worth just over \u00a31 billion across 96 months covering dose banded, patient specific and CIVAS cancer medicines alongside stock inventory management services, structured to serve NHS sites across South East, East Midlands and West Midlands England. Mid South Essex NHS Foundation Trust has published a contract notice","inLanguage":"ro-RO","isPartOf":{"@id":"https:\/\/hermix.com\/ro\/#website"},"breadcrumb":{"@id":"https:\/\/hermix.com\/ro\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\/#breadcrumblist"},"author":{"@id":"https:\/\/hermix.com\/ro\/author\/andreea-ilie\/#author"},"creator":{"@id":"https:\/\/hermix.com\/ro\/author\/andreea-ilie\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/hermix.com\/wp-content\/uploads\/2026\/05\/Mid-South-Essex-NHS-Foundation-Trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines_featured-image-1.png","@id":"https:\/\/hermix.com\/ro\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\/#mainImage","width":1200,"height":628,"caption":"Mid South Essex NHS Foundation-Trust public tender-for aseptically prepared systemic anti-cancer therapy medicines"},"primaryImageOfPage":{"@id":"https:\/\/hermix.com\/ro\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\/#mainImage"},"datePublished":"2026-05-18T15:52:00+03:00","dateModified":"2026-05-18T15:52:00+03:00"},{"@type":"WebSite","@id":"https:\/\/hermix.com\/ro\/#website","url":"https:\/\/hermix.com\/ro\/","name":"Hermix","description":"Win Public Contracts with the Power of AI","inLanguage":"ro-RO","publisher":{"@id":"https:\/\/hermix.com\/ro\/#organization"}}]},"og:locale":"ro_RO","og:site_name":"Hermix - Win Public Contracts with the Power of AI","og:type":"article","og:title":"Mid South Essex NHS Foundation Trust public tender for aseptically prepared systemic anti-cancer therapy medicines - Hermix","og:description":"View full tender data: https:\/\/app.hermix.com\/opportunities\/ukfts_033144-2026 A framework agreement worth just over \u00a31 billion across 96 months covering dose banded, patient specific and CIVAS cancer medicines alongside stock inventory management services, structured to serve NHS sites across South East, East Midlands and West Midlands England. Mid South Essex NHS Foundation Trust has published a contract notice","og:url":"https:\/\/hermix.com\/ro\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\/","og:image":"https:\/\/hermix.com\/wp-content\/uploads\/2026\/05\/Mid-South-Essex-NHS-Foundation-Trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines_featured-image-1.png","og:image:secure_url":"https:\/\/hermix.com\/wp-content\/uploads\/2026\/05\/Mid-South-Essex-NHS-Foundation-Trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines_featured-image-1.png","og:image:width":1200,"og:image:height":628,"article:published_time":"2026-05-18T13:52:00+00:00","article:modified_time":"2026-05-18T13:52:00+00:00","article:publisher":"https:\/\/www.facebook.com\/hermixapp","twitter:card":"summary_large_image","twitter:site":"@Hermix_sw","twitter:title":"Mid South Essex NHS Foundation Trust public tender for aseptically prepared systemic anti-cancer therapy medicines - Hermix","twitter:description":"View full tender data: https:\/\/app.hermix.com\/opportunities\/ukfts_033144-2026 A framework agreement worth just over \u00a31 billion across 96 months covering dose banded, patient specific and CIVAS cancer medicines alongside stock inventory management services, structured to serve NHS sites across South East, East Midlands and West Midlands England. Mid South Essex NHS Foundation Trust has published a contract notice","twitter:creator":"@Hermix_sw","twitter:image":"https:\/\/hermix.com\/wp-content\/uploads\/2026\/05\/Mid-South-Essex-NHS-Foundation-Trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines_featured-image-1.png"},"aioseo_meta_data":{"post_id":"7680","title":null,"description":null,"keywords":null,"keyphrases":{"focus":[],"additional":[]},"focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_custom_url":null,"og_image_custom_fields":null,"og_image_url":null,"og_image_width":null,"og_image_height":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_image_url":null,"twitter_title":null,"twitter_description":null,"schema_type":"default","schema_type_options":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"limit_modified_date":false,"ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":null,"created":"2026-08-13 01:26:50","updated":"2026-08-20 11:56:21"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/hermix.com\/ro\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/hermix.com\/ro\/category\/tender-analysis\/\" title=\"Tender Analysis\">Tender Analysis<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tMid South Essex NHS Foundation Trust public tender for aseptically prepared systemic anti-cancer therapy medicines\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/hermix.com\/ro"},{"label":"Tender Analysis","link":"https:\/\/hermix.com\/ro\/category\/tender-analysis\/"},{"label":"Mid South Essex NHS Foundation Trust public tender for aseptically prepared systemic anti-cancer therapy medicines","link":"https:\/\/hermix.com\/ro\/mid-south-essex-nhs-foundation-trust-public-tender-for-aseptically-prepared-systemic-anti-cancer-therapy-medicines\/"}],"authors":[{"term_id":17,"user_id":3,"is_guest":0,"slug":"andreea-ilie","display_name":"Andreea Ilie","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/cb0674b58c82c13f3140f57ce6b238abab5257f06d482468c588e76c72b29e8c?s=96&d=mm&r=g","author_category":"","first_name":"","last_name":"","user_url":"","job_title":"","description":""}],"_links":{"self":[{"href":"https:\/\/hermix.com\/ro\/wp-json\/wp\/v2\/posts\/7680","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hermix.com\/ro\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hermix.com\/ro\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hermix.com\/ro\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/hermix.com\/ro\/wp-json\/wp\/v2\/comments?post=7680"}],"version-history":[{"count":0,"href":"https:\/\/hermix.com\/ro\/wp-json\/wp\/v2\/posts\/7680\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hermix.com\/ro\/wp-json\/wp\/v2\/media\/7870"}],"wp:attachment":[{"href":"https:\/\/hermix.com\/ro\/wp-json\/wp\/v2\/media?parent=7680"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hermix.com\/ro\/wp-json\/wp\/v2\/categories?post=7680"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hermix.com\/ro\/wp-json\/wp\/v2\/tags?post=7680"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/hermix.com\/ro\/wp-json\/wp\/v2\/ppma_author?post=7680"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}